10PClinical and laboratory predictors of immune checkpoint inhibitor efficacy in non-small cell lung cancer. (17th December 2018) - Christopoulos, P; Kohlhäufl, J; Bozorgmehr, F; Kuon, J; Schneider, M; Neumann, O; Liersch, S; Heussel, C; Winter, H; Herth, F; Rieken, S; Muley, T; et al.